TEM-PCR™ Prospective Clinical Utility Study
Paused · Phase 4
Conditions studied: Upper Resp Tract Infection
In brief
This is a randomized, open-label, multi-center, prospective study to assess the clinical utility of the TEM-PCR Upper Respiratory Infection (URI) Panel in adult subjects age 65 and older presenting to the primary care clinic with symptoms of acute respiratory illness.
Key facts
- Study ID
- NCT04248361
- Run by
- Diatherix Laboratories, LLC
- People needed
- 314
- Starts
- 2020-03-06
- Expected to finish
- 2022-05-31
- Last updated by the study team
- 2021-08-20
Who can join
Age: 65 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Provide written informed consent for the trial;
- Age 65 years or older;
- In the opinion of the investigator, subject has the cognitive ability to provide accurate information to study site personnel and to follow instructions, or subject has a caregiver who can provide accurate information and ensure subject's compliance with instructions;
- Presentation with at least two of the following symptoms of acute respiratory illness:
- nasal congestion
- chest congestion
- shortness of breath
- cough
- body ache
- fever (≥100.4 ºF)
You may not qualify if…
- Subject is currently taking antibiotics or has taken antibiotics within the previous 30 days.
- Subject is currently taking antivirals or has taken antivirals within the previous 30 days.
- Subject has been hospitalized within the previous 30 days.
- Severity of illness (according to the Investigator) requires immediate hospitalization or referral to specialty care.
Where it is running
- Twilight Medical Center — Athens, Alabama, United States
- Valley Internal Medicine — Athens, Alabama, United States
- Blankenship Family Medicine — Huntsville, Alabama, United States
- Comprehensive Primary Care and Urgent Care of Alabama — Huntsville, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.